NCT Number: NCT00460902
Evaluation of the Deep TMS H-Coil in the Treatment of Major Depression- Augmentation of Antidepressant Medication
Evaluation of the novel deep TMS H-Coil design as an augmentation measure in the treatment of medication resistant major depression. Stimulation is administered with and without cognitive-emotional provocation.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 1 / Phase 2
Primary location
Beer Yaacov Medical Center, Beer Yaacov, Israel
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients diagnosed as suffering from treatment resistant major depression
- Right laterality
Exclusion criteria
- other major axis I diagnosis
- severe axis II diagnosis
- risk factors to convulsions
- history of drug abuse in the past year
Treatment and study plan
Primary outcomes
-
HAMILTON RATING SCALE FOR DEPRESSION 24 items
Time frame: 4 weeks
Sponsors and collaborators
Lead sponsor
Hadassah Medical Organization
Other
Registry information
Official study title
Evaluation of the H-Coil Transcranial Magnetic Stimulation(TMS) Device- Augmentation for Drug Resistant Depression
Important dates
- Study start
- 2007
- Primary completion
- 2009
- Study completion
- 2009
- First posted
- Apr 17, 2007
- Registry last updated
- Mar 20, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Neuroimaging Sleep and Mood in Depression
NCT05497414
Depressive Disorder, Depressive Disorder, Major
Boston, Massachusetts, United States
View Trial DetailsClinical Effectiveness of Choline Alphoscerate for Older Adults With Major Depression and Subjective Memory Complaints
NCT05257902
Depressive Disorder, Depressive Disorder, Major
Seoul, Irwon-dong, Gangnam-gu, South Korea
View Trial DetailsDepression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)
NCT01962753
Depressive Disorder, Depressive Disorder, Major
Besançon, France
View Trial DetailsThe Brain-Heart-Gut Connection
NCT06748274
Autonomous Dysfunction, Behavior
Bern, Canton of Bern, Switzerland
View Trial Details